Nov 8 (Reuters)-
SymBio Pharmaceuticals Limited
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2019 Sep 30, 2018 Dec 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.01 3.03 3.09
(-33.8 pct) (+25.5 pct) (-19.4 pct)
Operating loss 3.54 loss 1.91 loss 3.78
Recurring loss 3.64 loss 1.94 loss 3.86
Net loss 3.64 loss 1.94 loss 3.86
EPS loss 161.33 yen loss 125.23 yen loss 167.67 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - SymBio Pharmaceuticals Limited.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T